Canada’s Senate passes Bill on pharma patent changes

16-05-2017

Canada’s Senate passes Bill on pharma patent changes

mironovak / iStockphoto.com

The Senate of Canada has passed Bill C-30, which will change Canada’s pharma patent regulations including by allowing patent owners to recover patent term lost due to regulatory delays.


Canada, Bill C-30, intellectual property, Canada-European Union Comprehensive Economic and Trade Agreement, SPC, Canada’s Patent Act, patent restoration

LSIPR